New York Health Stock Odds of Future Stock Price Finishing Over 1.0E-4

BBAL Stock  USD 0.0001  0.00  0.00%   
New York's future price is the expected price of New York instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of New York Health performance during a given time horizon utilizing its historical volatility. Check out New York Analysis, New York Valuation, New York Correlation, New York Hype Analysis, New York Volatility, New York Price History as well as New York Performance.
Price Earnings To Growth Ratio is expected to rise to 0.03 this year, although the value of Price To Sales Ratio will most likely fall to 0.05. Please specify New York's target price for which you would like New York odds to be computed.

New York Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of New York for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for New York Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
New York Health generated a negative expected return over the last 90 days
New York Health has some characteristics of a very speculative penny stock
New York Health currently holds 25.64 K in liabilities. New York Health has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about New York's use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 44.4 M. Net Loss for the year was (1.05 M) with profit before overhead, payroll, taxes, and interest of 7.35 M.
New York Health currently holds about 5.37 M in cash with (88.61 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
New York Health has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Hims Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders - Reuters

New York Technical Analysis

New York's future price can be derived by breaking down and analyzing its technical indicators over time. New Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of New York Health. In general, you should focus on analyzing New Stock price patterns and their correlations with different microeconomic environments and drivers.

New York Predictive Forecast Models

New York's time-series forecasting models is one of many New York's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary New York's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about New York Health

Checking the ongoing alerts about New York for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for New York Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
New York Health generated a negative expected return over the last 90 days
New York Health has some characteristics of a very speculative penny stock
New York Health currently holds 25.64 K in liabilities. New York Health has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about New York's use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 44.4 M. Net Loss for the year was (1.05 M) with profit before overhead, payroll, taxes, and interest of 7.35 M.
New York Health currently holds about 5.37 M in cash with (88.61 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
New York Health has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Hims Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders - Reuters
When determining whether New York Health is a strong investment it is important to analyze New York's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact New York's future performance. For an informed investment choice regarding New Stock, refer to the following important reports:
Check out New York Analysis, New York Valuation, New York Correlation, New York Hype Analysis, New York Volatility, New York Price History as well as New York Performance.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of New York. Projected growth potential of New fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive New York assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Revenue Per Share
1.365
Quarterly Revenue Growth
(0.02)
Return On Assets
0.0364
The market value of New York Health is measured differently than its book value, which is the value of New that is recorded on the company's balance sheet. Investors also form their own opinion of New York's value that differs from its market value or its book value, called intrinsic value, which is New York's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because New York's market value can be influenced by many factors that don't directly affect New York's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between New York's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding New York should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, New York's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.